QS Investors, LLC - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 273 filers reported holding SAGE THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.75 and the average weighting 0.3%.

Quarter-by-quarter ownership
QS Investors, LLC ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$4,550,000
-24.1%
80,0900.0%0.05%
-22.9%
Q1 2021$5,995,000
+1159.5%
80,090
+1356.2%
0.07%
+1066.7%
Q4 2020$476,000
+41.2%
5,5000.0%0.01%
+20.0%
Q3 2020$337,000
-67.4%
5,500
-77.9%
0.01%
-64.3%
Q2 2020$1,034,000
+2147.8%
24,850
+1453.1%
0.01%
+1300.0%
Q1 2020$46,000
-61.0%
1,6000.0%0.00%0.0%
Q4 2019$118,000
-47.6%
1,6000.0%0.00%
-50.0%
Q3 2019$225,000
-23.2%
1,6000.0%0.00%
-33.3%
Q2 2019$293,000
+14.9%
1,6000.0%0.00%0.0%
Q1 2019$255,000
+65.6%
1,600
-0.3%
0.00%
+50.0%
Q4 2018$154,000
-32.2%
1,6050.0%0.00%0.0%
Q3 2018$227,000
-9.6%
1,6050.0%0.00%0.0%
Q2 2018$251,000
+93.1%
1,605
+99.4%
0.00%
+100.0%
Q1 2018$130,000
-2.3%
8050.0%0.00%0.0%
Q4 2017$133,000
+166.0%
805
+0.6%
0.00%
Q3 2017$50,000
-21.9%
8000.0%0.00%
-100.0%
Q2 2017$64,000
+12.3%
8000.0%0.00%
Q1 2017$57,0008000.00%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 5,149,482$105,976,3402.24%
Palo Alto Investors LP 1,005,776$20,698,8701.96%
Boxer Capital, LLC 1,094,000$22,514,5201.20%
Bellevue Group AG 3,513,351$72,304,7641.16%
PDT Partners, LLC 181,625$3,737,8430.47%
EASTERLY INVESTMENT PARTNERS LLC 195,643$4,026,3330.44%
Harvest Investment Services, LLC 30,302$623,6150.40%
Simplify Asset Management Inc. 120,030$2,470,2170.28%
SAMLYN CAPITAL, LLC 739,867$15,226,4630.25%
CAXTON ASSOCIATES LP 68,035$1,400,1600.19%
View complete list of SAGE THERAPEUTICS INC shareholders